Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren/Amlodipine vs Amlodipine Monotherapy on Ankle Foot Volume
NCT01080768Phase 2Terminated
- Sponsor
- Novartis
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Feb 2010; status: terminated.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01080768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080768.